Literature DB >> 7065727

Neutrophil function in systemic lupus erythematosus and other collagen diseases.

H Al-Hadithy, D A Isenberg, I E Addison, A H Goldstone, M L Snaith.   

Abstract

Using a whole blood technique we assessed neutrophil migration, phagocytosis, and killing in a group of 20 patients with systemic lupus erythematosus (SLE) and in 8 patients with other connective tissue disorders. In the untreated cases of SLE neutrophil migration was significantly depressed, but it was usually normal in the treated group. This may be attributable either to an intrinsic neutrophil abnormality or to a humoral factor. Although isolated abnormalities of phagocytosis and killing were observed in SLE, these functions were normal when the patients were considered as a group. The treated patients with other collagen diseases showed enhanced migration in both autologous and control plasma, normal phagocytosis, and enhanced killing in autologous plasma only. The small group of untreated, non-SLE patients showed some depression of all 3 functions. There was no correlation between neutrophil function and clinical activity of disease. In the SLE patients there was no correlation between neutrophil function and circulating immune complexes.

Entities:  

Mesh:

Year:  1982        PMID: 7065727      PMCID: PMC1000860          DOI: 10.1136/ard.41.1.33

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  22 in total

1.  "Streaking leukocyte factor," arthritis, and pyoderma gangrenosum.

Authors:  J C Jacobs; E J Goetzl
Journal:  Pediatrics       Date:  1975-10       Impact factor: 7.124

2.  Altered neutrophil function induced by serum from patients with systemic lupus erythematosus.

Authors:  G W Notani; A J Kenyon; R B Zurier
Journal:  Adv Exp Med Biol       Date:  1976       Impact factor: 2.622

3.  Impaired phagocytosis by peripheral blood granulocytes in systemic lupus erythematosus.

Authors:  L Brandt; H Hedberg
Journal:  Scand J Haematol       Date:  1969

4.  Detection of antibodies and soluble antigen-antibody complexes by precipitation with polyethylene glycol.

Authors:  W D Creighton; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

5.  Neutrophil chemotaxis in systemic lupus erythematosus.

Authors:  R A Clark; H R Kimball; J L Decker
Journal:  Ann Rheum Dis       Date:  1974-03       Impact factor: 19.103

6.  Chemotaxis of polymorphonuclear leukocytes from patients with systemic lupus erythematosus and Felty's syndrome.

Authors:  M Zivkovic; J Baum
Journal:  Immunol Commun       Date:  1972

7.  Reduction of phagocytosis and lysosomal enzyme release from human leukocytes by serum from patients with systemic lupus erythematosus.

Authors:  R B Zurier
Journal:  Arthritis Rheum       Date:  1976 Jan-Feb

8.  An investigation of leukocyte function and phagocytosis of immune complexes in patients with rheumatoid arthritis.

Authors:  K Okuda; R Okamoto; Y Noguchi; I Tadokoro
Journal:  Jpn J Exp Med       Date:  1975-02

9.  Immunoglobulin phagocytosis by granulocytes from sera and synovial fluids in various rheumatoid and nonrheumatoid diseases.

Authors:  A Cats; G J Lafeber; F Klein
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

10.  Phagocytic function of polymorphonuclear leukocytes in rheumatic diseases.

Authors:  R A Turner; R Schumacher; A R Myers
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

View more
  3 in total

1.  Neutrophil enzyme activities in carrageenan-induced inflammation in rats.

Authors:  I Sopata; E Wojtecka-Lukasik; J Wize; S Maśliński
Journal:  Agents Actions       Date:  1989-08

2.  Abnormal monocyte cytotoxicity and cyclic-AMP levels in systemic sclerosis.

Authors:  T Herlin; J Eggert; K Kragballe; H Zachariae
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

3.  Neutrophil gelatinase levels in plasma and synovial fluid of patients with rheumatic diseases.

Authors:  I Sopata; J Wize; A Filipowicz-Sosnowska; E Stanisławska-Biernat; B Brzezińska; S Maśliński
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.